Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Total Liabilities (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Total Liabilities readings, the most recent being $725.9 million for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 3.03% to $725.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $725.9 million, a 3.03% increase, with the full-year FY2025 number at $725.9 million, up 3.03% from a year prior.
  • Total Liabilities hit $725.9 million in Q4 2025 for Tandem Diabetes Care, down from $741.7 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $766.9 million in Q1 2025 to a low of $440.9 million in Q1 2021.
  • Median Total Liabilities over the past 5 years was $625.8 million (2022), compared with a mean of $626.3 million.
  • Biggest five-year swings in Total Liabilities: soared 223.8% in 2021 and later rose 0.03% in 2023.
  • Tandem Diabetes Care's Total Liabilities stood at $472.0 million in 2021, then rose by 29.83% to $612.8 million in 2022, then rose by 4.27% to $639.0 million in 2023, then grew by 10.26% to $704.6 million in 2024, then rose by 3.03% to $725.9 million in 2025.
  • The last three reported values for Total Liabilities were $725.9 million (Q4 2025), $741.7 million (Q3 2025), and $742.5 million (Q2 2025) per Business Quant data.